Perioperative management for CRS and HIPEC Anesthesiological aspects

Bleiler, D. and Bleiler, S. and Sinner, B. (2018) Perioperative management for CRS and HIPEC Anesthesiological aspects. CHIRURG, 89 (9). pp. 687-692. ISSN 0009-4722, 1433-0385

Full text not available from this repository. (Request a copy)

Abstract

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are therapeutic options for the treatment of intra-abdominal neoplasms. Following the resection of all visible tumor areas by CRS, microscopic tumor areas are treated with HIPEC. This procedure increases the quality of life and survival. The CRS with HIPEC is a complex surgical procedure in which the mainly younger and often otherwise healthy patients undergo several pathophysiological changes during the operation. The main concern of the anesthesiologist is the massive volume loss, volume shift and metabolic alterations. Patients with a high comorbidity should undergo preoperative optimization to reduce the perioperative morbidity and mortality especially by protracted interventions.

Item Type: Article
Uncontrolled Keywords: HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; QUALITY-OF-LIFE; CYTOREDUCTIVE SURGERY; ANESTHETIC MANAGEMENT; COAGULOPATHY; MORBIDITY; THERAPY; CANCER; Abdominal neoplasms; Anesthesiology; Volume management; Coagulation management; Postoperative analgesia
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Anästhesiologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 09 Jan 2020 08:04
Last Modified: 09 Jan 2020 08:04
URI: https://pred.uni-regensburg.de/id/eprint/13974

Actions (login required)

View Item View Item